LIVN.NASDAQLivanova PLC

Form 4: LivaNova Director Brooke Story Reports Routine Equity Transactions and New RSU Grant

Sentiment:

Insider Transaction Report


LivaNova PLC Director Brooke Story filed a Form 4 detailing the vesting of restricted stock units, a tax-related share disposition, and the grant of new equity awards.

Summary

  • Brooke Story, a Director of LivaNova PLC (LIVN), reported several equity transactions on June 15, 2025, as detailed in a Form 4 filing.
  • Ms. Story acquired 3,416 ordinary shares through the vesting and settlement of previously granted Restricted Stock Units (RSUs) under the Company's 2015 Incentive Award Plan.
  • Concurrently, 410 ordinary shares were disposed of at a price of $45.76 per share to satisfy tax liabilities associated with the RSU vesting.
  • Following these transactions, Ms. Story's direct beneficial ownership of ordinary shares stands at 6,482.
  • Additionally, Ms. Story was granted 4,042 new Restricted Stock Units under the Company's 2025 Director Incentive Award Plan.
  • These newly granted RSUs are scheduled to vest on June 15, 2026, contingent upon continued service during the vesting period.
  • After all reported transactions, Ms. Story holds 4,042 unvested Restricted Stock Units.

Sentiment

Score: 5

Explanation: The filing details routine insider transactions related to equity compensation (vesting, tax withholding, new grant) and does not indicate any unusual or significant positive/negative developments for the company or its stock price, thus maintaining a neutral sentiment.

Positives

  • Grant of 4,042 new Restricted Stock Units (RSUs) under the 2025 Director Incentive Award Plan, indicating continued equity-based compensation and alignment of director interests with shareholder value.
  • Vesting of 3,416 Restricted Stock Units, converting contingent rights into direct ownership of ordinary shares for the reporting person.

Negatives

  • Disposal of 410 ordinary shares at $45.76 to satisfy tax liabilities, which results in a reduction of direct share ownership.

Future Outlook

The document indicates that 4,042 newly granted Restricted Stock Units are scheduled to vest on June 15, 2026, subject to continued service during the vesting period.

Industry Context

This Form 4 filing details routine insider equity transactions for a director of a publicly traded medical technology company. Such filings are standard disclosures and do not typically reflect broader industry trends, but rather individual compensation and ownership changes within the company.

Stakeholder Impact

  • Shareholders: Provides transparency regarding director compensation and changes in insider ownership, which is a routine aspect of corporate governance and executive compensation.
  • Employees: While not directly impacted by this specific director transaction, the existence of incentive award plans generally aligns the interests of key personnel with the company's performance.

Next Steps

  • The 4,042 Restricted Stock Units granted on June 15, 2025, are expected to vest on June 15, 2026, subject to the reporting person's continued service.

Key Dates

DateDescription
06/15/2024Grant date of Restricted Stock Units (RSUs) that vested on June 15, 2025.
06/15/2025Date of RSU vesting, acquisition of ordinary shares, disposal of shares for tax liability, and grant of new Restricted Stock Units.
06/17/2025Date the Form 4 filing was signed by the reporting person's attorney-in-fact.
06/15/2026Vesting date for the 4,042 Restricted Stock Units granted on June 15, 2025, subject to continued service.

Keywords

LivaNova PLC, LIVN, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Equity Compensation, Director Compensation, Share Ownership, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.